IGC News and Press, India Globalization Capital Inc. From 12/01/20

Gainers: Corporacion America Airports (CAAP) +47%. Arlo Technologies (ARLO) +30%. Professional Diversity Network (IPDN) +13%. Grupo Aeroportuario del Centro Norte (OMAB) +12%. Quad/Graphics (QUAD) +11%.Losers: India Globalization Capital (IGC) -17%. Fuel Tech (FTEK) -17%. ENGlo...

Gainers: India Globalization Capital (IGC) +31%. Navios Maritime (NM) +19%. TOMI Environmental Solutions (TOMZ) +16%. Euroseas (ESEA) +9%. Star Bulk Carriers (SBLK) +8%.Losers: Fuel Tech (FTEK) -12%. Pioneer Power Solutions (PPSI) -10%. ENGlobal (E...

Gainers: China Automotive Systems (CAAS) +77%.Sundial Growers (SNDL) +63%.Veritone (VERI) +47%.AquaBounty Technologies (AQB) +42%.Marathon Patent Group (MARA) +34%.FSD Pharma (HUGE) +33%.Apollo Endosurgery (APEN) +28%.India Globalization Capital (IGC) +25%.Codiak BioSciences (CDAK) +24%.Riot ...

Sunesis Pharmaceuticals (SNSS) +50% after announcing merger agreement with Viracta Therapeutics.China Automotive Systems (CAAS) +32% on guiding 2021 sales boom.India Globalization Capital (IGC) +24%.Ameri Holdings (AMRH) +26%.Oramed Pharmaceuticals (ORMP) +24%.Navios ...

Are These On Your List Of Penny Stocks To Watch For December 2020? The month of November has already shown itself to be quite good for penny stocks . During the past few weeks, many popular stocks under $5 have shot up in value. This, of course, is not across the board, but there ar...

Are These On Your List Of Penny Stocks To Buy Right Now? Are you looking for penny stocks on Robinhood to buy for under a certain price? With the millions of brand new accounts that’ve been opened on the app, there’s a big thing lacking. I’m not talking about th...

India Globalization Capital ([[IGC]]) has commenced Phase 1 clinical trial on its Investigational Drug Candidate, IGC-AD1, investigational cannabinoid formulation, for patients with mild to severe dementia due to Alzheimer’s diseaseThe study began enrolling participants suffering ...

India Globalization Capital, Inc. (“IGC” or the “Company”) (NYSE American: IGC) announced that it is enrolling participants suffering from mild to severe dementia due to Alzheimer’s disease for its Phase 1 clinical trial. Our subsidiary, IGC Pharma...

India Globalization Capital (IGC): FQ2 GAAP EPS of -$0.04.Revenue of $0.13M (-92.9% Y/Y)Press Release For further details see: India Globalization Capital reports FQ2 results

India Globalization Capital, Inc. (“IGC” or the “Company”) (NYSE American: IGC) today announced its financial results for the quarter ended September 30, 2020, which is the second quarter of its 2021 fiscal year, and the start of Phase 1 cannabinoid-based cli...